• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于 NMR 的代谢组学新方法用于胆管癌的诊断。

A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer.

机构信息

Department of Biochemistry, Inha University Hospital and Center for Advanced Medical Education by BK21 Project, College of Medicine, Inha University, Incheon, Republic of Korea.

出版信息

J Hepatol. 2010 Feb;52(2):228-33. doi: 10.1016/j.jhep.2009.11.002. Epub 2009 Nov 27.

DOI:10.1016/j.jhep.2009.11.002
PMID:20036026
Abstract

BACKGROUND & AIMS: Biliary tract cancer is highly lethal at presentation, with increasing mortality worldwide. Current diagnostic measures employing multiple criteria such as imaging, cytology, and serum tumor markers are not satisfactory, and a new diagnostic tool is needed. Because bile is a cognate metabolite-rich bio-fluid in the biliary ductal system, we tested a new metabolomic approach to develop an effective diagnostic tool.

METHODS

Biles were collected prospectively from patients with cancer (n=17) or benign biliary tract diseases (n=21) with percutaneous or endoscopic methods. Nuclear magnetic resonance spectra (NMR) of these biles were analyzed using orthogonal partial least square discriminant analysis (OPLS-DA).

RESULTS

The metabolomic 2-D score plot showed good separation between cancer and benign groups. The contributing NMR signals were analyzed using a statistical TOCSY approach. The diagnostic performance assessed by leave-one-out analysis exhibited 88% sensitivity and 81% specificity, better than the conventional markers (CEA, CA19-9, and bile cytology).

CONCLUSION

The NMR-based metabolomics approach provides good performance in discriminating cancer and benign biliary duct diseases. The excellent predictability of the method suggests that it can, at least, augment the currently available diagnostic approaches.

摘要

背景与目的

胆道癌在发病时具有高度致命性,全球死亡率不断上升。目前采用多种标准(如影像学、细胞学和血清肿瘤标志物)的诊断措施并不令人满意,需要一种新的诊断工具。由于胆汁是胆管系统中同源代谢产物丰富的生物液体,我们测试了一种新的代谢组学方法来开发有效的诊断工具。

方法

通过经皮或内镜方法前瞻性地从癌症(n=17)或良性胆道疾病(n=21)患者中收集胆汁。使用正交偏最小二乘判别分析(OPLS-DA)对这些胆汁的核磁共振光谱(NMR)进行分析。

结果

代谢组学二维得分图显示癌症和良性组之间有良好的分离。使用统计 TOCSY 方法分析了有贡献的 NMR 信号。通过留一法分析评估的诊断性能显示出 88%的敏感性和 81%的特异性,优于传统标志物(CEA、CA19-9 和胆汁细胞学)。

结论

基于 NMR 的代谢组学方法在区分癌症和良性胆管疾病方面具有良好的性能。该方法具有出色的预测性,表明它至少可以增强当前可用的诊断方法。

相似文献

1
A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer.一种基于 NMR 的代谢组学新方法用于胆管癌的诊断。
J Hepatol. 2010 Feb;52(2):228-33. doi: 10.1016/j.jhep.2009.11.002. Epub 2009 Nov 27.
2
Identification of bile biomarkers of biliary tract cancer through a liquid chromatography/mass spectrometry-based metabolomic method.通过基于液相色谱/质谱的代谢组学方法鉴定胆道癌的胆汁生物标志物。
Mol Med Rep. 2015 Mar;11(3):2191-8. doi: 10.3892/mmr.2014.2973. Epub 2014 Nov 18.
3
Comparative analysis of targeted metabolomics: dominance-based rough set approach versus orthogonal partial least square-discriminant analysis.靶向代谢组学的比较分析:基于优势的粗糙集方法与正交偏最小二乘判别分析
J Biomed Inform. 2015 Feb;53:291-9. doi: 10.1016/j.jbi.2014.12.001. Epub 2014 Dec 11.
4
Usefulness of bile cytology in the diagnostic management of patients with biliary tract obstruction.胆汁细胞学检查在胆道梗阻患者诊断处理中的应用价值。
Acta Cytol. 1985 Mar-Apr;29(2):93-100.
5
Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.紫藤凝集素唾液酸化粘蛋白核心多肽1是胆管癌和肝内胆管癌的敏感生物标志物:一项多中心研究。
J Gastroenterol. 2017 Feb;52(2):218-228. doi: 10.1007/s00535-016-1230-0. Epub 2016 Jun 29.
6
Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.基于核磁共振技术的维吾尔族原发性高血压患者血浆代谢组学研究
Eur Rev Med Pharmacol Sci. 2014;18(23):3673-80.
7
Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease?血清和胆汁癌胚抗原及糖类抗原19-9测定对于鉴别良性和恶性胆道疾病是否可靠?
Turk J Gastroenterol. 2003 Sep;14(3):181-4.
8
Fibronectin in human bile fluid for diagnosis of malignant biliary diseases.人胆汁中的纤连蛋白用于恶性胆道疾病的诊断。
Hepatology. 1996 Mar;23(3):423-8. doi: 10.1002/hep.510230305.
9
Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma.Mac-2结合蛋白是胆道癌的一种诊断标志物。
Cancer. 2004 Oct 1;101(7):1609-15. doi: 10.1002/cncr.20469.
10
Carcinoembryonic antigen in the bile in patients with pancreatic and biliary cancer. Correlation with cytology and percutaneous transhepatic cholangiography.胰腺癌和胆管癌患者胆汁中的癌胚抗原。与细胞学及经皮肝穿刺胆管造影的相关性。
Cancer. 1982 Dec 15;50(12):2903-9. doi: 10.1002/1097-0142(19821215)50:12<2903::aid-cncr2820501233>3.0.co;2-m.

引用本文的文献

1
Metabolomics of Duodenal Juice for Biliary Tract Cancer Diagnosis.用于胆管癌诊断的十二指肠液代谢组学
Cancers (Basel). 2023 Sep 1;15(17):4370. doi: 10.3390/cancers15174370.
2
Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers.胆汁生物标志物及其在胆道肿瘤中的免疫调节作用的研究进展。
Front Immunol. 2022 Oct 28;13:1049812. doi: 10.3389/fimmu.2022.1049812. eCollection 2022.
3
Ex vivo NMR metabolomics approach using cerebrospinal fluid for the diagnosis of primary CNS lymphoma: Correlation with MR imaging characteristics.
采用脑脊液的体外 NMR 代谢组学方法诊断原发性中枢神经系统淋巴瘤:与磁共振成像特征的相关性。
Cancer Med. 2023 Feb;12(4):4679-4689. doi: 10.1002/cam4.5083. Epub 2022 Aug 8.
4
Gas chromatography-mass spectrometry-based untargeted metabolomics reveals metabolic perturbations in medullary thyroid carcinoma.基于气相色谱-质谱联用的非靶向代谢组学揭示了甲状腺髓样癌中的代谢紊乱。
Sci Rep. 2022 May 19;12(1):8397. doi: 10.1038/s41598-022-12590-x.
5
The Effect of Blood Contained in the Samples on the Metabolomic Profile of Mouse Brain Tissue: A Study by NMR Spectroscopy.血液对小鼠脑组织代谢组学图谱的影响:NMR 光谱研究。
Molecules. 2021 May 22;26(11):3096. doi: 10.3390/molecules26113096.
6
Serum microRNAs as Biomarkers for the Noninvasive Early Diagnosis of Biliary Tract Cancer.血清微小RNA作为胆道癌非侵入性早期诊断的生物标志物
Int J Gen Med. 2021 Apr 1;14:1185-1195. doi: 10.2147/IJGM.S297371. eCollection 2021.
7
Serum metabolite profiling of a 4-Nitroquinoline-1-oxide-induced experimental oral carcinogenesis model using gas chromatography-mass spectrometry.使用气相色谱-质谱联用技术对4-硝基喹啉-1-氧化物诱导的实验性口腔癌发生模型进行血清代谢物谱分析。
PeerJ. 2021 Jan 4;9:e10619. doi: 10.7717/peerj.10619. eCollection 2021.
8
Screening for Early Gastric Cancer Using a Noninvasive Urine Metabolomics Approach.使用非侵入性尿液代谢组学方法筛查早期胃癌
Cancers (Basel). 2020 Oct 9;12(10):2904. doi: 10.3390/cancers12102904.
9
Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs.通过测序血清 microRNAs 鉴定胰腺和胆道癌诊断的潜在生物标志物。
BMC Med Genomics. 2019 May 16;12(1):62. doi: 10.1186/s12920-019-0521-8.
10
Current state of nonsurgical therapies for cholangiocarcinoma.胆管癌非手术治疗的现状
Hepat Oncol. 2014 Jan;1(1):135-142. doi: 10.2217/hep.13.9. Epub 2013 Dec 20.